We are live on ! Find out more

Micro Cap Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
MCRB icon
126
Seres Therapeutics
MCRB
$47.4M
$47.4M $4.72 1.72%
VERU icon
127
Veru
VERU
$46.7M
$46.7M $2.74 1.79%
MGX icon
128
Metagenomi Therapeutics
MGX
$46.1M
$46.1M $1.22 0.83%
KPTI icon
129
Karyopharm Therapeutics
KPTI
$46M
$46M $2.03 3.33%
FLNA
130
Filana Therapeutics
FLNA
$45.1M
$45.1M $0.9333 3.94%
GRCE
131
Grace Therapeutics
GRCE
$44.2M
$44.2M $2.10 0.94%
ALGS icon
132
Aligos Therapeutics
ALGS
$43.7M
$43.7M $7 3.85%
CNTX icon
133
Context Therapeutics
CNTX
$43.2M
$43.2M $0.4699 0.88%
CRVO icon
134
CervoMed
CRVO
$41.5M
$41.5M $3.07 0.65%
HYPD
135
Hyperion DeFi Inc
HYPD
$40.8M
$40.8M $2.69 1.89%
APLM icon
136
Apollomics
APLM
$37.5M
$37.5M $17.06 6.06%
NTRB icon
137
Nutriband
NTRB
$37.4M
$37.4M $3.08 3.14%
NXTC icon
138
NextCure
NXTC
$37.4M
$37.4M $8.17 21.4%
LTRN icon
139
Lantern Pharma
LTRN
$33.9M
$33.9M $2.66 4.32%
DYAI icon
140
Dyadic International
DYAI
$32.1M
$32.1M $0.8800 16.2%
ESLA icon
141
Estrella Immunopharma
ESLA
$31.8M
$31.8M $0.7401 4.96%
QNCX icon
142
Quince Therapeutics
QNCX
$31.8M
$31.8M $31.26 4.49%
LITS
143
Lite Strategy Inc
LITS
$31.4M
$31.4M $0.9215 2.25%
ENLV icon
144
Enlivex Ltd
ENLV
$31M
$31M $1.84 4.17%
BYSI icon
145
BeyondSpring
BYSI
$30.5M
$30.5M $0.7420 6.08%
BCTX
146
Briacell Therapeutics
BCTX
$29.7M
$29.7M $3.41 1.16%
KYNB
147
Kyntra Bio
KYNB
$28.7M
$28.7M $7.10 0.42%
JSPR icon
148
Jasper Therapeutics
JSPR
$27.4M
$27.4M $0.8239 7.75%
TVGN icon
149
Tevogen Inc. Common Stock
TVGN
$27.3M
$27.3M $6.47 2.71%
EVAX
150
Evaxion A/S
EVAX
$25.6M
$25.6M $3.07 0.33%
4 5
6
7 8

Micro Cap Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 273 micro cap Biotechnology stocks — companies in the Biotechnology industry with a market cap under $250M — worth a combined $18.3B.

The largest by market cap are Greenwich LifeSciences (GLSI) at $248M, Adagene (ADAG) at $248M and Capricor Therapeutics (CAPR) at $243M.

Among institutional investors, Atrium Therapeutics (RNA) drew the most net new fund positions in Q1 2026: 162 funds opened new positions.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.